Follicular Lymphoma CME Patient Education

Overview of Follicular Lymphoma: New CME

Posted on

A new follicular lymphoma CME program worth 1 AMA PRA Category 1 Credits™, is now available on demand. Find it here.  In the Western hemisphere, follicular lymphoma (FL) is the most common non-Hodgkin lymphoma (NHL). In the US in 2018, it is expected that approximately 74,680 new cases of NHL will be diagnosed and 20% […]

Read More

Follicular Lymphoma Patient Education

Managing Your Cancer as a Chronic Disease

Posted on

Current statistics estimate that this year, of the 1,735,350 new cases of cancer that will be diagnosed in the United States, over 1.1 million people will face the challenges of continuing to live a meaningful life with cancer. While everyone has heard about the rigors of and side effects than can accompany cancer treatments such […]

Read More

ASCO 2019 floorplan

PlatformQ Health & OMedLive at ASCO 2018

Posted on

Our commitment to oncology practice and cancer care makes ASCO 2018 one of the most exciting events for our team, because it gives us an opportunity to explain how we’re improving healthcare outcomes through trusted digital education for people with cancer. […]

Read More

Carcinoid Syndrome Patient Education

Carcinoid Syndrome: The Tumor and the Hormones

Posted on

He lay there in the ICU bed with his family standing by in the waiting area. As the intern on call, I was called to his bedside once again because his blood pressure plunged dangerously low. Unfortunately, his prognosis was poor, in fact terminal. The medical team knew this would be the last time he […]

Read More

Prostate Cancer CME

Ground-Breaking PRECISION Study Results: MRI Superior for Prostate Cancer

Posted on

Currently, the guidelines around prostate cancer for physicians like me follow are murky, and best practices are subject to debate by different medical organizations. A widely-known recommendation called a PSA (Prostate Specific Antigen) screening, for example, has been fraught with failings and blamed for causing an unacceptable number of unnecessary prostate biopsies. On March 19, […]

Read More

NHL Patient Educational Outcomes

Online Patient Education Drives Meaningful Outcomes

Posted on

The inaugural program for CancerCoachLive, PlatformQ Health’s educational channel for online patient education about different forms of cancer, was launched in 2016 through a partnership with The Leukemia & Lymphoma Society (LLS) focusing on educating patients with B-cell non-Hodgkin lymphomas (NHL).  Building on LLS’s goal to empower patients through education, this program aimed to improve knowledge […]

Read More

Acute Myeloid Leukemia (AML) Patient Education

A Review of Acute Myeloid Leukemia (AML)

Posted on

Acute myelogenous/myeloid leukemia (AML) is one of the malignant diseases of the bone marrow. In this disease, hematopoietic precursor cells become arrested in early stages of development. Typically, AML is distinguished from other blood disorders by the presence of greater than 20% blasts seen in the bone marrow.  AML has many names including acute myelocytic […]

Read More

rare disease zebra

Rare Diseases: Why We All Need to be Aware

Posted on

While rare diseases are uncommon, there are a multitude of them. In the US, there are approximately 7,000 diseases that are considered to be rare. It is approximated that there are nearly 300,000,000 patients around the world who are diagnosed with a rare disease. In the US, a rare disease is defined as any disease […]

Read More

Pancreatic Cancer CME

Pancreatic Cancer: How Long Will it Remain “Incurable”?

Posted on

As medical students and residents, we were taught to fear pancreatic cancer. As most people know, the cure rate is dismal and the majority of victims die within the first year of diagnosis. While this has been improving over the past years, the low five year survival rate persists. According to the American Cancer Society, […]

Read More

Prepare for doctor appointment

Colorectal Cancer Around the Globe

Posted on

Colorectal cancer is one of the most common cancers in the US, as well as around the world. Additionally, it remains one of the leading causes of cancer deaths as well. Our knowledge of this deadly disease increased exponentially in recent years and we now have screening tests and a plethora of treatment modalities. Yet, […]

Read More

Patient and caregiver talking to doctor

Metastatic Colon Cancer Can be a Preventable Disease

Posted on

Colorectal cancer is the third leading cause of cancer death in the US. The American Cancer Society (ACS) reported that there will be over 95,000 new cases of colon cancer and over 39,000 cases of rectal cancer in the US in 2016.  Men have a 1 in 21 lifetime risk of developing colorectal cancer whereas […]

Read More

PlatformQ Health CME

Cases, Challenges, and Controversies on High-Risk Pediatric Neuroblastoma

Posted on

This OMEDLIVE presentation is Part Two of a two-part series surrounding Pediatric Neuroblastoma. During the conversation, Dr. Jason Shohet and Jennifer Saggio, MSN, CRNP, CPON focus on the following areas: Overview of pathology and standard therapy for high-risk NB Required imaging and evaluations for the revised INRGSS system Overall treatment scheme, including recent proposed changes […]

Read More

lung

The Genetics of Lung Cancer

Posted on

Everyone is aware of the link between cigarette smoking and lung cancer. However, recent research is showing strong genetic contributors to the development of these cancers. Even among smokers, genetics appear to play some role. Not every smoker develops lung cancer and not everyone who develops lung cancer smokes. Here, we’ll review the genetics of […]

Read More

global

GASTRIC CANCER: A GLOBAL VIEW

Posted on

Gastric cancer, also known as stomach cancer, remains an aggressive cancer around the globe. Over the past several decades, there has been a slight decrease in incidence, yet it remains the fourth most common cancer and the second deadliest across the world.  Some factors that are thought to be responsible for the declining incidence include […]

Read More

patient and doctor

Breast Cancer in Men: Where we are in 2016

Posted on

While everyone is aware that breast cancer in woman exists, many do not know men can be similarly afflicted. Breast cancer in women has its own awareness month (October) and its own symbol of awareness, the pink ribbon. Breast cancer in men, on the other hand, do not even have treatments tailored to them but […]

Read More

leukemia

Treatment Options for Chronic Lymphocytic Leukemia (CLL)

Posted on

Chronic Lymphocytic Leukemia (CLL) is the most prevalent type of adult leukemia, with a median age of diagnosis of 72. However, 10 percent of patients are under age 50, twice as common in men as it is in women. There is a genetic predisposition; an environmental predisposition is uncertain, although Vietnam Veterans with Agent Orange […]

Read More

World Cancer Day 2016

Our First CME World Cancer Day Challenge

Posted on

  When did learning give back so much? From today through February 10th, join our World Cancer Day Challenge to earn CME and help us donate to cancer research at the same time! For every OMedLive session you attend, we’ll donate $10 to the American Cancer Society. For every CME credit hour claimed, we’ll boost […]

Read More

NSCLC lung cancer

Advanced NSCLC: Clinical Challenges for Personalized Treatment

Posted on

According to the American Cancer Society, there were approximately 221,000 new cases of lung cancer in the U.S. in 2015. These patients accounted for about 13% of all new cancers. Of those, nearly 85-to-90 percent are non-small cell lung cancer (NSCLC). In this offering from OMedLive, Drs. Panos Fidias and Mark Socinski address some of […]

Read More

Biosimilars

Biosimilars: The coming impact on American medicine

Posted on

In March of 2015, the FDA approved the first biosimilar for use with American patients. In the next five years, the biosimilars market is expected to expand to $60 billion in sales in the U.S. and $127 billion worldwide. On February 1st, from 10 am – noon, EST, OMedLive in partnership with ClinicalSeriesLive, will be […]

Read More

blood

Nursing Perspectives for Optimizing Hemophilia Treatment

Posted on

In this OMedLive video, nurses Brenda Riske and Regina B. Butler discuss “optimizing outcomes in hemophilia treatment” from a nurse’s perspective. Hemophilia, a genetic bleeding disease, affects about 20,000 Americans and over 400,000 people worldwide. A rare and serious condition, it requires a vigilant medical team for optimal patient care. Brenda Riske, RN, MSN, MBA, […]

Read More